This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kendall Law Group Investigates Millipore Corporation For Investors

Kendall Law Group investigates Millipore Corporation (NYSE:MIL) for investors concerning the proposed acquisition of Millipore by Merck KGaA. The national securities firm is concerned that the Board of Directors of Millipore may have breached their fiduciary duties by entering into an agreement that is unfair to shareholders, without seeking other deals that may have better represented the value of the company. If you are a MIL shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at hlindley@kendalllawgroup.com.

On February 28, 2010, the companies announced that they had entered into an agreement for Millipore to be acquired by Merck in a $7.2 billion transaction. According to the agreement, shareholders will receive $107.00 in cash per MIL share owned, only 13% over the $94.41 closing price before the deal was announced. The transaction is expected to close during the second half of 2010.

Kendall Law Group, founded by former federal judge Joe Kendall, has been counsel in dozens of merger and acquisition cases nationwide, including some of the largest transactions in the United States. The firm includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. Protect your rights as a MIL shareholder by calling the firm.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
MIL $4.01 0.00%
AAPL $126.44 0.00%
FB $87.28 0.00%
GOOG $523.40 0.00%
TSLA $280.02 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs